Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (35)

2024

  1. Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice

    Viruses, Vol. 16, Núm. 3

  2. Multiscale and multimodal evaluation of autosomal dominant polycystic kidney disease development

    Communications Biology, Vol. 7, Núm. 1

  3. The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues

    Journal of Biological Engineering, Vol. 18, Núm. 1

2023

  1. NatB Catalytic Subunit Depletion Disrupts DNA Replication Initiation Leading to Senescence in MEFs

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2021

  1. Aav-hdv: An attractive platform for the in vivo study of hdv biology and the mechanism of disease pathogenesis

    Viruses, Vol. 13, Núm. 5

  2. Oligonucleotide-based therapies for renal diseases

    Biomedicines, Vol. 9, Núm. 3

  3. Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 6, pp. 1369-1381

2020

  1. Maturation of NAA20 Aminoterminal End Is Essential to Assemble NatB N-Terminal Acetyltransferase Complex

    Journal of Molecular Biology, Vol. 432, Núm. 22, pp. 5889-5901

  2. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity

    Neurobiology of Disease, Vol. 137

2018

  1. Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))

    Journal of Hepatology

  2. N-terminal acetylation modulates Bax targeting to mitochondria

    International Journal of Biochemistry and Cell Biology, Vol. 95, pp. 35-42

2017

  1. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

    Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679

  2. NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

    Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981

  3. Use of thymidine kinase recombinant adenovirus and ganciclovir mediated mouse liver preconditioning for hepatocyte xenotransplantation

    Methods in Molecular Biology (Humana Press Inc.), pp. 179-192

2016

  1. Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis

    Journal of Immunology, Vol. 197, Núm. 6, pp. 2145-2156

2015

  1. Animal models of chronic hepatitis delta virus infection host–virus immunologic interactions

    Pathogens, Vol. 4, Núm. 1, pp. 46-65

  2. Cold preservation of human adult hepatocytes for liver cell therapy

    Cell Transplantation, Vol. 24, Núm. 12, pp. 2541-2555

2014

  1. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection

    Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489

  2. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

  3. Image analysis for the quantitative comparison of stress fibers and focal adhesions

    PLoS ONE, Vol. 9, Núm. 9